152 related articles for article (PubMed ID: 37523428)
1. Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study.
Chia A; Ngo C; Choudry N; Yamakawa Y; Tan D
Asia Pac J Ophthalmol (Phila); 2023 Jul-Aug 01; 12(4):370-376. PubMed ID: 37523428
[TBL] [Abstract][Full Text] [Related]
2. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
3. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
[TBL] [Abstract][Full Text] [Related]
4. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
[TBL] [Abstract][Full Text] [Related]
6. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
Chia A; Lu QS; Tan D
Ophthalmology; 2016 Feb; 123(2):391-399. PubMed ID: 26271839
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.
Hieda O; Hiraoka T; Fujikado T; Ishiko S; Hasebe S; Torii H; Takahashi H; Nakamura Y; Sotozono C; Oshika T; Morimoto T; Nishida K; Nishikawa N; Song YS; Tokutake T; Nishi Y; Shigeno Y; Kurihara T; Negishi K; Tsubota K; Ono M; Nakai T; Tan D; Tanaka S; Kinoshita S;
Jpn J Ophthalmol; 2021 May; 65(3):315-325. PubMed ID: 33586090
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.
Hansen NC; Hvid-Hansen A; Møller F; Bek T; Larsen DA; Jacobsen N; Kessel L
BMC Ophthalmol; 2023 Oct; 23(1):438. PubMed ID: 37904082
[TBL] [Abstract][Full Text] [Related]
10. Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression.
Pérez-Flores I; Macías-Murelaga B; ; Barrio-Barrio J
Sci Rep; 2023 Sep; 13(1):16310. PubMed ID: 37770602
[TBL] [Abstract][Full Text] [Related]
11. Low Dose Atropine in Preventing the Progression of Childhood Myopia: A Randomised Controlled Trial.
Sharma I; Das GK; Rohatgi J; Sahu PK; Chhabra P; Bhatia R
Curr Eye Res; 2023 Apr; 48(4):402-407. PubMed ID: 36576170
[TBL] [Abstract][Full Text] [Related]
12. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
[TBL] [Abstract][Full Text] [Related]
13. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of 1% Atropine on Retardation of Moderate Myopia Progression in Chinese School Children.
Zhu Q; Tang Y; Guo L; Tighe S; Zhou Y; Zhang X; Zhang J; Zhu Y; Hu M
Int J Med Sci; 2020; 17(2):176-181. PubMed ID: 32038101
[No Abstract] [Full Text] [Related]
15. Atropine for the treatment of childhood myopia.
Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
[TBL] [Abstract][Full Text] [Related]
16. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048
[TBL] [Abstract][Full Text] [Related]
17. Myopia outcome study of atropine in children: Two-year result of daily 0.01% atropine in a European population.
Loughman J; Kobia-Acquah E; Lingham G; Butler J; Loskutova E; Mackey DA; Lee SSY; Flitcroft DI
Acta Ophthalmol; 2024 May; 102(3):e245-e256. PubMed ID: 37694816
[TBL] [Abstract][Full Text] [Related]
18. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
Chia A; Chua WH; Wen L; Fong A; Goon YY; Tan D
Am J Ophthalmol; 2014 Feb; 157(2):451-457.e1. PubMed ID: 24315293
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of atropine 1% in children with low myopia.
Yi S; Huang Y; Yu SZ; Chen XJ; Yi H; Zeng XL
J AAPOS; 2015 Oct; 19(5):426-9. PubMed ID: 26228967
[TBL] [Abstract][Full Text] [Related]
20. Myopia progression and axial elongation in Spanish children: Efficacy of atropine 0.01% eye-drops.
Moriche-Carretero M; Revilla-Amores R; Diaz-Valle D; Morales-Fernández L; Gomez-de-Liaño R
J Fr Ophtalmol; 2021 Dec; 44(10):1499-1504. PubMed ID: 34774348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
